Loading…
Oculis Holding AG is projected to rise to $48.15 by 2027, a +63% move from its current price of $29.61. OCS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $28.71 | $29.64 | $30.60 | +0.10% |
| May 30 | $28.36 | $29.67 | $31.03 | +0.19% |
| May 31 | $28.10 | $29.69 | $31.38 | +0.29% |
| Jun 1 | $27.89 | $29.72 | $31.68 | +0.38% |
| Jun 2 | $27.70 | $29.75 | $31.95 | +0.48% |
| Jun 3 | $27.54 | $29.78 | $32.20 | +0.57% |
| Jun 4 | $27.40 | $29.81 | $32.43 | +0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $27.40 | $29.81 | $32.43 | +0.67% |
| Week 2 | $26.63 | $30.01 | $33.81 | +1.34% |
| Week 3 | $26.10 | $30.21 | $34.96 | +2.02% |
| Week 4 | $25.69 | $30.41 | $36.00 | +2.70% |
| Week 5 | $25.35 | $30.61 | $36.97 | +3.39% |
| Week 6 | $25.07 | $30.82 | $37.89 | +4.08% |
| Week 7 | $24.82 | $31.03 | $38.78 | +4.78% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Oculis Holding AG is a clinical-stage biopharmaceutical company that develops drug candidates to treat ophthalmic, neuro-ophthalmic, and neurological diseases in Switzerland and internationally. The company operates in the healthcare sector and works on therapies across its focused eye and neurological programs.
OCS is the stock of Oculis Holding AG. It is currently priced at $29.49 with a market capitalization of $1.78B. It is ranked 2081 in the market.
A major floor 21.1% below — a decisive break under it would weaken the trend.
The nearest floor, 10.7% below — buyers have tended to step in here.
The nearest ceiling, 10.3% above — a clean break opens room to run.
A major ceiling 20.8% above — clearing it would confirm fresh momentum.
Key OCS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of OCS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $29.59 | Buy | $29.63 | Sell |
| MA 10 | $29.59 | Buy | $29.60 | Buy |
| MA 20 | $29.48 | Buy | $29.28 | Buy |
| MA 50 | $27.68 | Buy | $28.26 | Buy |
| MA 100 | $27.21 | Buy | $26.73 | Buy |
| MA 200 | $23.14 | Buy | $24.31 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.54 | Neutral |
| Stoch RSI (14) | 22.77 | Neutral |
| CCI (20) | 5.89 | Neutral |
| Williams %R (14) | -64.14 | Info |
| MACD (12,26,9) | -0.13 | Sell |
| ROC (12) | -9.28 | Sell |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 35.86 | Neutral |
| TRIX (15) | 0.35 | Buy |
| Awesome (5,34) | 1.00 | Buy |
| Ultimate (7,14,28) | 48.16 | Neutral |
| Momentum (10) | -0.80 | Sell |
| Aroon Osc (25) | 44.00 | Buy |
| Hull MA (9) | 30.09 | Sell |
| ADX (14) | 14.36 | Neutral |
| ATR (14) | 0.90 | Info |
The 30-day technical picture is bullish, with RSI14 at 50 and the price trading around key moving averages. The stock is above the 50-day simple moving average of $27.52 and above the 200-day simple moving average of $23.02.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $19.75 | $29.61 | $48.10 | 0% | Neutral | |
| $37.56 | $48.15 | $65.73 | +63% | Bullish | |
| $42.05 | $55.67 | $79.15 | +88% | Bullish | |
| $47.43 | $64.52 | $94.72 | +118% | Bullish | |
| $47.71 | $66.48 | $100.28 | +125% | Bullish | |
| $53.99 | $76.93 | $118.81 | +160% | Bullish | |
| $70.63 | $102.75 | $162.07 | +247% | Bullish | |
| $82.61 | $122.55 | $197.05 | +314% | Bullish | |
| $88.10 | $133.17 | $217.93 | +350% | Bullish | |
| $90.42 | $139.15 | $231.46 | +370% | Bullish | |
| $151.08 | $252.48 | $449.63 | +753% | Bullish | |
| $275.89 | $533.19 | $1,048.18 | +17.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $19.75 | $29.61 | $35.20 | +0.00% |
| June 2026 | $26.97 | $31.79 | $38.45 | +7.38% |
| July 2026 | $27.13 | $32.30 | $39.68 | +1.59% |
| August 2026 | $28.05 | $33.65 | $41.83 | +4.18% |
| September 2026 | $29.62 | $35.76 | $44.88 | +6.26% |
| October 2026 | $29.82 | $36.21 | $45.86 | +1.28% |
| November 2026 | $29.44 | $35.94 | $45.87 | -0.75% |
| December 2026 | $30.50 | $37.42 | $48.10 | +4.11% |
Click any year to see its month-by-month OCS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The OCS price prediction for 2026 points to an average of $29.61 (low $19.75, high $48.10) — a potential gain of 0% on today's $29.61. Price action looks broadly range-bound.
In 2027, OCS is projected to trade between $37.56 and $65.73, averaging $48.15 — a potential gain of +63% from today's $29.61. That is up +63% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Oculis Holding AG's 2028 outlook centres on $55.67, within a $42.05 to $79.15 range. That is up +16% on the projected 2027 average. That marks a +88% change versus current levels. Momentum favours further upside here.
By 2029, OCS could reach as high as $94.72, with a base case around $64.52 and support toward $47.43 — roughly +118% from $29.61. Buyers look set to stay in control over this stretch.
Expect OCS to range from $47.71 to $100.28 through 2030. The $66.48 average target implies a +125% move from current prices. That is up +3% on the projected 2029 average. Momentum favours further upside here.
The OCS price prediction for 2031 points to an average of $76.93 (low $53.99, high $118.81) — a potential gain of +160% on today's $29.61. Buyers look set to stay in control over this stretch.
In 2032, OCS is projected to trade between $70.63 and $162.07, averaging $102.75 — a potential gain of +247% from today's $29.61. That is up +34% on the projected 2031 average. Momentum favours further upside here.
Oculis Holding AG's 2033 outlook centres on $122.55, within a $82.61 to $197.05 range. That is up +19% on the projected 2032 average. That marks a +314% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, OCS could reach as high as $217.93, with a base case around $133.17 and support toward $88.10 — roughly +350% from $29.61. Momentum favours further upside here.
Expect OCS to range from $90.42 to $231.46 through 2035. The $139.15 average target implies a +370% move from current prices. That is up +4% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The OCS price prediction for 2040 points to an average of $252.48 (low $151.08, high $449.63) — a potential gain of +753% on today's $29.61. Momentum favours further upside here.
In 2050, OCS is projected to trade between $275.89 and $1,048.18, averaging $533.19 — a potential gain of +17.0x from today's $29.61. That is up +111% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in OCS today (≈ 33.772374 OCS) could be worth
$18,007.01
+$17,007.01 (+1701%) by 2050 · US Dollar
Based on the average projected OCS price of $533.19 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in OCSwould be worth at today's price.
$1,000 invested in OCS on May 27, 2025 (≈ 50.276522 OCS) would be worth
$1,488.69
+$488.69 (+48.9%) today · 1.49× · US Dollar
Based on a OCS entry price of $19.89 vs. today's $29.61.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $27.91 | $1,060.91 | +6.1% |
| 1 month ago | $27.12 | $1,091.81 | +9.2% |
| 3 months ago | $29.99 | $987.33 | -1.3% |
| 6 months ago | $19 | $1,558.42 | +55.8% |
| 1 year ago | $19.89 | $1,488.69 | +48.9% |
| All time (5.0y) ago | $9.71 | $3,049.43 | +204.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our OCS forecast.
Our base-case forecast reaches $59.00 around 2029.
Implied market cap at $59.00: $3.56B
The multi-year forecast shows a rising path for the average price: 2026 avg $29.49, 2027 avg $48.89, 2028 avg $56.48, 2029 avg $66.16, 2030 avg $67.26, 2031 avg $78.70, 2032 avg $107.73, 2033 avg $126.73, 2034 avg $138.13, 2035 avg $145.87, 2040 avg $266.31, 2050 avg $571.54. Projected ROIs rise across years, with 2027 ROI 65.8%, 2028 91.5%, 2029 124.3%, 2030 128.1%, 2031 166.9%, 2032 265.3%, 2033 329.7%, 2034 368.4%, 2035 394.6%, 2040 803%, and 2050 1838.1%. These are estimates and not guarantees, and the forecast assumes future market conditions and development progress.
The sentiment remains BULLISH across the long horizon, reflecting the expected upside.
Tap a question to reveal the answer.
Avg $67.26, min $47.67, max $102.82, ROI 128.1%, sentiment BULLISH.
Forecasts show bullish sentiment from 2027 onward with rising averages (e.g., 2027 avg $48.89; 2030 avg $67.26) and positive ROI (e.g., 2027 ROI 65.8%, 2030 ROI 128.1%). 2026 is Neutral.
Yes. The 2030 max forecast is $102.82, with higher maxs in later years (2032 max $172.54, 2033 max $207.04).
Current price $29.49; market cap $1.78B.
Sentiment BULLISH; RSI14 50; SMA50 $27.52; SMA200 $23.02; support $26.44; resistance $32.65; 30-day range $23.62-$36.82.
Oculis Holding AG Community Discussion
0Share your Oculis Holding AG price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.